Intervention of Ovarian Cancer With Antigen-specific Engineered Immune Effectors
Condition(s):Ovarian CancerLast Updated:July 31, 2018Suspended
Hide Studies Not Open or Pending
Condition(s):Ovarian CancerLast Updated:July 31, 2018Suspended
Condition(s):Ovarian CancerLast Updated:December 7, 2022Not yet recruiting
Condition(s):Epithelial Ovarian CancerLast Updated:October 17, 2023Completed
Condition(s):Ovarian CancerLast Updated:December 4, 2014Terminated
Condition(s):Ovarian CancerLast Updated:November 13, 2023Recruiting
Condition(s):Ovarian CancerLast Updated:September 17, 2013Unknown status
Condition(s):Epithelial Ovarian CancerLast Updated:March 17, 2016Completed
Condition(s):Ovarian CancerLast Updated:May 17, 2023Recruiting
Condition(s):Ovarian CancerLast Updated:December 18, 2013Completed
Condition(s):Ovarian CancerLast Updated:June 10, 2013Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.